Obeticholic acid: expanding the therapeutic landscape of NASH

被引：5

作者：

Arrese, Marco ^{[1
]}

Cabrera, Daniel ^{[1
]}

Barrera, Francisco ^{[1
]}

机构：

[1] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago 8330024, Chile

来源：

ANNALS OF HEPATOLOGY | 2015年 / 14卷 / 03期

关键词：

FATTY LIVER-DISEASE; BILE-ACID; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; INFLAMMATION; FXR;

D O I：

10.1016/S1665-2681(19)31286-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：430 / 432

页数：3

共 19 条

[1] Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis [J].

Adorini, Luciano ;

Pruzanski, Mark ;

Shapiro, David .

DRUG DISCOVERY TODAY, 2012, 17 (17-18) :988-997

[2] Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance? [J].

Angulo, Paul .

HEPATOLOGY, 2010, 51 (02) :373-375

[3] Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases [J].

Arrese, M. ;

Karpen, S. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) :473-478

[4] New horizons in the regulation of bile acid and lipid homeostasis: critical role of the nuclear receptor FXR as an intracellular bile acid sensor [J].

Arrese, M ;

Karpen, SJ .

GUT, 2001, 49 (04) :465-466

[5] FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease [J].

Carr, Rotonya M. ;

Reid, Andrea E. .

CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (04)

[6] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].

Chalasani, Naga ;

Younossi, Zobair ;

Lavine, Joel E. ;

Diehl, Anna Mae ;

Brunt, Elizabeth M. ;

Cusi, Kenneth ;

Charlton, Michael ;

Sanyal, Arun J. .

GASTROENTEROLOGY, 2012, 142 (07) :1592-1609

[7] Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid [J].

Hirschfield, Gideon M. ;

Mason, Andrew ;

Luketic, Velimir ;

Lindor, Keith ;

Gordon, Stuart C. ;

Mayo, Marlyn ;

Kowdley, Kris V. ;

Vincent, Catherine ;

Bodhenheimer, Henry C., Jr. ;

Pares, Albert ;

Trauner, Michael ;

Marschall, Hanns-Ulrich ;

Adorini, Luciano ;

Sciacca, Cathi ;

Beecher-Jones, Tessa ;

Castelloe, Erin ;

Boehm, Olaf ;

Shapiro, David .

GASTROENTEROLOGY, 2015, 148 (04) :751-U347

[8] Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet [J].

Kong, Bo ;

Luyendyk, James P. ;

Tawfik, Ossama ;

Guo, Grace L. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01) :116-122

[9] Bile acid receptors in non-alcoholic fatty liver disease [J].

Li, Yuanyuan ;

Jadhav, Kavita ;

Zhang, Yanqiao .

BIOCHEMICAL PHARMACOLOGY, 2013, 86 (11) :1517-1524

[10] Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target [J].

Liu, Wen-Yue ;

Xie, Dong-Mei ;

Zhu, Gui-Qi ;

Huang, Gui-Qian ;

Lin, Yi-Qian ;

Wang, Li-Ren ;

Shi, Ke-Qing ;

Hu, Bin ;

Braddock, Martin ;

Chen, Yong-Ping ;

Zheng, Ming-Hua .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (05) :675-685

← 1 2 →